Cardio Total Other Income Expense Net vs Ebitda Analysis

CDIOW Stock

USD 0.04 0 9.24%

Cardio Diagnostics financial indicator trend analysis is way more than just evaluating Cardio Diagnostics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardio Diagnostics is a good investment. Please check the relationship between Cardio Diagnostics Total Other Income Expense Net and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Total Other Income Expense Net vs Ebitda

Total Other Income Expense Net vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardio Diagnostics Total Other Income Expense Net account and Ebitda. At this time, the significance of the direction appears to have very week relationship.

The correlation between Cardio Diagnostics' Total Other Income Expense Net and Ebitda is 0.29. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Ebitda in the same time period over historical financial statements of Cardio Diagnostics Holdings, assuming nothing else is changed. The correlation between historical values of Cardio Diagnostics' Total Other Income Expense Net and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Cardio Diagnostics Holdings are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Total Other Income Expense Net i.e., Cardio Diagnostics' Total Other Income Expense Net and Ebitda go up and down completely randomly.

Correlation Coefficient

0.29

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Other Income Expense Net

Ebitda

Most indicators from Cardio Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardio Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

At this time, Cardio Diagnostics' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to climb to about 37.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2023	2024 (projected)
Reconciled Depreciation	16K	53.8K	56.5K
Total Operating Expenses	621.3K	7.3M	7.6M

Reconciled Depreciation Total Operating Expenses

Cardio Diagnostics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Inventory	Non Current Liabilities Other	Short Long Term Debt Total	Current Deferred Revenue	Non Currrent Assets Other	Short Term Debt
Total Assets		-0.72	0.83	0.99	-0.68	-0.78	0.91	0.94	0.63	0.94	-0.33	1.0	0.84	0.96	0.99	0.98	-0.95	0.97	0.85	-0.95	-0.5	-0.5	0.58	0.57	0.58	-0.57
Other Current Liab	-0.72		-0.48	-0.73	1.0	0.15	-0.91	-0.89	0.06	-0.89	0.64	-0.67	-0.26	-0.68	-0.73	-0.83	0.53	-0.85	-0.3	0.53	-0.13	-0.13	0.14	0.14	0.13	-0.14
Total Current Liabilities	0.83	-0.48		0.77	-0.47	-0.71	0.73	0.73	0.58	0.73	0.21	0.82	0.73	0.94	0.77	0.78	-0.9	0.73	0.68	-0.9	-0.45	-0.45	0.59	0.57	0.61	-0.55
Total Stockholder Equity	0.99	-0.73	0.77		-0.67	-0.78	0.9	0.93	0.63	0.93	-0.41	0.99	0.84	0.93	1.0	0.98	-0.92	0.97	0.86	-0.92	-0.5	-0.5	0.58	0.57	0.57	-0.56
Net Debt	-0.68	1.0	-0.47	-0.67		0.08	-0.89	-0.86	0.13	-0.86	0.61	-0.61	-0.19	-0.65	-0.67	-0.79	0.48	-0.81	-0.22	0.48	-0.2	-0.2	0.21	0.21	0.2	-0.21
Retained Earnings	-0.78	0.15	-0.71	-0.78	0.08		-0.51	-0.57	-0.98	-0.57	-0.03	-0.82	-0.99	-0.76	-0.78	-0.68	0.89	-0.65	-0.93	0.89	0.89	0.89	-0.95	-0.96	-0.93	0.96
Accounts Payable	0.91	-0.91	0.73	0.9	-0.89	-0.51		0.99	0.32	0.99	-0.48	0.86	0.6	0.89	0.9	0.97	-0.82	0.97	0.55	-0.82	-0.26	-0.26	0.23	0.24	0.21	-0.25
Cash	0.94	-0.89	0.73	0.93	-0.86	-0.57	0.99		0.39	1.0	-0.5	0.9	0.66	0.9	0.93	0.99	-0.85	0.99	0.62	-0.85	-0.32	-0.32	0.3	0.31	0.28	-0.32
Non Current Assets Total	0.63	0.06	0.58	0.63	0.13	-0.98	0.32	0.39		0.39	0.11	0.68	0.95	0.6	0.63	0.51	-0.78	0.48	0.87	-0.78	-0.95	-0.95	0.98	1.0	0.96	-1.0
Cash And Short Term Investments	0.94	-0.89	0.73	0.93	-0.86	-0.57	0.99	1.0	0.39		-0.5	0.9	0.66	0.9	0.93	0.99	-0.85	0.99	0.62	-0.85	-0.32	-0.32	0.3	0.31	0.28	-0.32
Common Stock Shares Outstanding	-0.33	0.64	0.21	-0.41	0.61	-0.03	-0.48	-0.5	0.11	-0.5		-0.3	-0.08	-0.11	-0.41	-0.44	0.1	-0.51	-0.12	0.1	-0.07	-0.07	0.25	0.2	0.28	-0.18
Other Current Assets	1.0	-0.67	0.82	0.99	-0.61	-0.82	0.86	0.9	0.68	0.9	-0.3		0.87	0.95	0.99	0.96	-0.95	0.95	0.89	-0.95	-0.54	-0.54	0.65	0.63	0.65	-0.62
Other Stockholder Equity	0.84	-0.26	0.73	0.84	-0.19	-0.99	0.6	0.66	0.95	0.66	-0.08	0.87		0.8	0.84	0.76	-0.93	0.73	0.93	-0.93	-0.87	-0.87	0.9	0.92	0.88	-0.92
Total Liab	0.96	-0.68	0.94	0.93	-0.65	-0.76	0.89	0.9	0.6	0.9	-0.11	0.95	0.8		0.93	0.94	-0.96	0.91	0.77	-0.96	-0.47	-0.47	0.57	0.55	0.58	-0.55
Net Invested Capital	0.99	-0.73	0.77	1.0	-0.67	-0.78	0.9	0.93	0.63	0.93	-0.41	0.99	0.84	0.93		0.98	-0.92	0.97	0.86	-0.92	-0.5	-0.5	0.58	0.57	0.57	-0.56
Total Current Assets	0.98	-0.83	0.78	0.98	-0.79	-0.68	0.97	0.99	0.51	0.99	-0.44	0.96	0.76	0.94	0.98		-0.9	1.0	0.74	-0.9	-0.41	-0.41	0.43	0.44	0.43	-0.44
Capital Stock	-0.95	0.53	-0.9	-0.92	0.48	0.89	-0.82	-0.85	-0.78	-0.85	0.1	-0.95	-0.93	-0.96	-0.92	-0.9		-0.88	-0.84	1.0	0.7	0.7	-0.73	-0.74	-0.71	0.74
Net Working Capital	0.97	-0.85	0.73	0.97	-0.81	-0.65	0.97	0.99	0.48	0.99	-0.51	0.95	0.73	0.91	0.97	1.0	-0.88		0.72	-0.88	-0.39	-0.39	0.4	0.41	0.39	-0.41
Intangible Assets	0.85	-0.3	0.68	0.86	-0.22	-0.93	0.55	0.62	0.87	0.62	-0.12	0.89	0.93	0.77	0.86	0.74	-0.84	0.72		-0.84	-0.69	-0.69	0.87	0.84	0.89	-0.83
Common Stock	-0.95	0.53	-0.9	-0.92	0.48	0.89	-0.82	-0.85	-0.78	-0.85	0.1	-0.95	-0.93	-0.96	-0.92	-0.9	1.0	-0.88	-0.84		0.7	0.7	-0.73	-0.74	-0.71	0.74
Inventory	-0.5	-0.13	-0.45	-0.5	-0.2	0.89	-0.26	-0.32	-0.95	-0.32	-0.07	-0.54	-0.87	-0.47	-0.5	-0.41	0.7	-0.39	-0.69	0.7		1.0	-0.88	-0.94	-0.83	0.95
Non Current Liabilities Other	-0.5	-0.13	-0.45	-0.5	-0.2	0.89	-0.26	-0.32	-0.95	-0.32	-0.07	-0.54	-0.87	-0.47	-0.5	-0.41	0.7	-0.39	-0.69	0.7	1.0		-0.88	-0.94	-0.83	0.95
Short Long Term Debt Total	0.58	0.14	0.59	0.58	0.21	-0.95	0.23	0.3	0.98	0.3	0.25	0.65	0.9	0.57	0.58	0.43	-0.73	0.4	0.87	-0.73	-0.88	-0.88		0.99	0.99	-0.98
Current Deferred Revenue	0.57	0.14	0.57	0.57	0.21	-0.96	0.24	0.31	1.0	0.31	0.2	0.63	0.92	0.55	0.57	0.44	-0.74	0.41	0.84	-0.74	-0.94	-0.94	0.99		0.97	-1.0
Non Currrent Assets Other	0.58	0.13	0.61	0.57	0.2	-0.93	0.21	0.28	0.96	0.28	0.28	0.65	0.88	0.58	0.57	0.43	-0.71	0.39	0.89	-0.71	-0.83	-0.83	0.99	0.97		-0.96
Short Term Debt	-0.57	-0.14	-0.55	-0.56	-0.21	0.96	-0.25	-0.32	-1.0	-0.32	-0.18	-0.62	-0.92	-0.55	-0.56	-0.44	0.74	-0.41	-0.83	0.74	0.95	0.95	-0.98	-1.0	-0.96

Click cells to compare fundamentals

Cardio Diagnostics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardio Total Other Income Expense Net vs Ebitda Analysis

Total Other Income Expense Net vs Ebitda

Total Other Income Expense Net vs Ebitda Correlation Analysis

Correlation Coefficient

Total Other Income Expense Net

Ebitda

Cardio Diagnostics fundamental ratios Correlations

Cardio Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Cardio Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Assets	+ 1.0	Total Assets
Net Debt	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Current Deferred Revenue	+ 1.0	Non Current Assets Total
Net Working Capital	+ 1.0	Total Current Assets

Short Term Debt	- 1.0	Current Deferred Revenue
Short Term Debt	- 1.0	Non Current Assets Total
Other Stockholder Equity	- 0.99	Retained Earnings
Short Term Debt	- 0.98	Short Long Term Debt Total
Non Current Assets Total	- 0.98	Retained Earnings
Short Term Debt	- 0.96	Non Currrent Assets Other